Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients

Restore Medical secures €2.5 million in EU funding for cardiac implants to treat heart failure

Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients
